|
| 36333195 | Development of a web-based, theory-guided narrative intervention for women at elevated risk for breast cancer. | Patient Educ Couns | 2023 |
| 37337090 | Assessing the general public's view of direct-to-consumer (DTC) genetic testing and their interpretation of DTC website disclaimer messages. | Eur J Hum Genet | 2023 |
| 34998598 | Hospital-based ovarian cancer patient traceback program results in minimal genetic testing uptake. | Gynecol Oncol | 2022 |
| 35626031 | Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond <i>BRCA1</i> and <i>BRCA2</i> in Breast and Ovarian Cancer Patients. | Cancers (Basel) | 2022 |
| 35180772 | Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study. | Clin Cancer Res | 2022 |
| 34213370 | MRI Volumetrics and Image Texture Analysis in Assessing Systemic Treatment Response in Extra-Abdominal Desmoid Fibromatosis. | Radiol Imaging Cancer | 2021 |
| 33822054 | mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in patients with juvenile polyposis of infancy with PTEN-BMPR1A deletion. | Hum Mol Genet | 2021 |
| 33507482 | Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series. | Breast Cancer Res Treat | 2021 |
| 30418620 | Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer. | Transl Behav Med | 2020 |
| 29460110 | Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing. | J Genet Couns | 2018 |
| 30046027 | Early Outcome Data Assessing Utility of a Post-Test Genomic Counseling Framework for the Scalable Delivery of Precision Health. | J Pers Med | 2018 |
| 30540989 | How Online Family History Tool Design and Message Content Impact User Perceptions: An Examination of Family HealthLink. | Public Health Genomics | 2018 |
| 27322592 | EMR documentation of physician-patient communication following genomic counseling for actionable complex disease and pharmacogenomic results. | Clin Genet | 2017 |
| 28181117 | CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure. | Pharm Res | 2017 |
| 28345121 | Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports. | J Genet Couns | 2017 |
| 28491196 | Cerebral palsy and seizures in a child with tubulinopathy pattern dysgenesis and focal cortical dysplasia. | Radiol Case Rep | 2017 |
| 29181084 | Clinical pharmacogenomics: patient perspectives of pharmacogenomic testing and the incidence of actionable test results in a chronic disease cohort. | Per Med | 2017 |
| 27582512 | Lack of evidence for germline <i>RNF43</i> mutations in patients with serrated polyposis syndrome from a large multinational study. | Gut | 2017 |
| 27921197 | Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research Study. | J Genet Couns | 2017 |
| 26306685 | Genetic Knowledge Among Participants in the Coriell Personalized Medicine Collaborative. | J Genet Couns | 2016 |
| 25356968 | Clinically relevant lessons from Family HealthLink: a cancer and coronary heart disease familial risk assessment tool. | Genet Med | 2015 |
| 23725378 | Linking distant relatives with BRCA gene mutations: potential for cost savings. | Clin Genet | 2014 |
| 24926413 | Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease. | J Pers Med | 2014 |
| 24504939 | Teaching genomic counseling: preparing the genetic counseling workforce for the genomic era. | J Genet Couns | 2014 |
| 23211288 | Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. | Am J Surg Pathol | 2013 |
| 23651015 | Implementation of a clinical research pharmacogenomics program at an academic medical center: role of the genetics healthcare professional. | Pharmacogenomics | 2013 |
| 23805267 | Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome. | PLoS One | 2013 |
| 23588301 | The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. | Clin Pharmacol Ther | 2013 |
| 21834074 | The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. | Int J Cancer | 2012 |
| 22790859 | Serrated polyposis is an underdiagnosed and unclear syndrome: the surgical pathologist has a role in improving detection. | Am J Surg Pathol | 2012 |
| 22510757 | Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. | Am J Surg Pathol | 2012 |
| 22525305 | Cancer risks for relatives of patients with serrated polyposis. | Am J Gastroenterol | 2012 |
| 22594506 | Program in pharmacogenomics at the Ohio State University Medical Center. | Pharmacogenomics | 2012 |
| 22144499 | Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). | Cancer Epidemiol Biomarkers Prev | 2012 |
| 19543972 | Characterization of BRCA1 ring finger variants of uncertain significance. | Breast Cancer Res Treat | 2010 |
| 21098759 | Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. | J Natl Cancer Inst | 2010 |
| 20541936 | Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers. | Breast | 2010 |
| 20661287 | Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. | PLoS One | 2010 |
| 20213458 | Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. | Int J Colorectal Dis | 2010 |
| 19463493 | Cancer risk and risk communication in urban, lower-income neighborhoods. | Prev Med | 2009 |
| 19340607 | Methylation not a frequent "second hit" in tumors with germline BRCA mutations. | Fam Cancer | 2009 |
| 18493129 | Lessons learned while developing a cancer family history campaign in the Columbus, Ohio metropolitan area. | Community Genet | 2008 |
| 18824701 | Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance. | J Clin Oncol | 2008 |
| 17204050 | In search of a familial cancer risk assessment tool. | Clin Genet | 2007 |
| 17914333 | Management options after prophylactic surgeries in women with BRCA mutations: a review. | Cancer Control | 2007 |
| 15841079 | Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors. | Br J Cancer | 2005 |
| 16287957 | Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. | JAMA | 2005 |
| 14757853 | Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. | J Med Genet | 2004 |
| 15235018 | Genetic aetiology of diffuse gastric cancer: so near, yet so far. | J Med Genet | 2004 |
| 15322516 | Highly penetrant hereditary cancer syndromes. | Oncogene | 2004 |